Skip to main content

Prescribed health apps Market Research Insights Shared in Detailed Report 2019, forecast 2023

Prescribed health apps are software applications designed to provide health services over mobile devices. They assist patients by managing their medical condition in real-time and gaining advice from medical professionals via the mobile phone.
The ubiquitousness of smartphones and smart devices have ensured the development of mobile applications. These health applications allow monitoring patient’s daily routine by the professionals for critical health issues. All the medical records of a patient can be stored in a single device.
The global prescribed health apps market Size is predicted to exhibit a Enormous Growth of 47.1% CAGR from 2017 to 2024.
Prescribed Health Apps Market is often used as an accessory to a regulated apps) and helping physicians during their clinical decision-making By Operating System (Windows, Androids, iPhones) By Devices (Diabetes management device, multi-parameter tracker, cardiac monitoring device) – Global Forecast to 2024.
Prescribed health apps Market Segmentation
The prescribed health apps market is segmented by type, device, application, and end-user.
By type –          Windows, Android, iPhone, and others.
By device–        multi-parameter tracker, cardiac monitoring device, diabetes management device, and others.
By application– lifestyle management, disease management, fitness, nutrition, and diet, medication adherence, and others.
By end-user–    home care, specialty centers, hospitals, sand others.
TABLE OF CONTENTS:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Prescribed Health Apps Market, By Product
6.1 Introduction
6.2 Windows
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3 Androids
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.4 IPhones
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.5 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 7. Global Prescribed Health Apps Market, By Application
7.1 Introduction
7.2 Diabetes Management Device
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.3 Multi-Parameter Tracker
Continued…
Major Competitive Outlook
BioTelemetry Inc., AirStrip Technologies, LifeWatch AG, Sanofi, Apple, Inc., iHealth Lab, and Cerner Corporation are some of the major players in the prescribed health apps market. Traditional players are developing healthcare applications to digitize their offerings and gain a larger consumer base.
Access Complete Premium Report Details of “Global Prescribed Health apps Market Research Report – Forecast to 2024” at: https://www.marketresearchfuture.com/reports/global-prescribed-health-apps-market-758
Geographically the Prescribed Health Apps Market is segmented into Asia Pacific (APAC), America, Middle East & Africa (MEA), and Europe are regions covered in the global prescribed health apps market report.
Industry Updates
Mar 2019 A Seattle-based digital prescribing platform, Xealth, has successfully raised USD 11 million in Series A funding from Novartis, McKesson Ventures, Philips, and ResMed. The existing investors are UPMC and Froedtert, Providence Ventures, Threshold Ventures, and the Medical College of Wisconsin health network which had also participated in the funding round.
Jan 2019 Otsuka is planning on working together with Click Therapeutics to develop and commercialize a ‘prescription digital therapeutic’ for major depressive disorder (MDD). Otsuka will assign capital to entirely fund the growth of Click’s mobile app ‘CT-152’ for MDD, and to commercialize it globally upon attainment of regulatory approvals.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

Comments

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...